Chinook Therapeutics, Inc.
KDNYDelisted Aug 11, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001435049
Chinook Therapeutics, Inc. was delisted on Aug 11, 2023; its insiders filed their last Form 4 on Aug 11, 2023; 185 institutions reported holding it in 13F filings for Q2 2023, worth $2.24B in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Chinook Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 151
- +16 vs. Q2 2022
- Shares held
- 57.4M
- +3.90M (+7.3%) vs. Q2 2022
- Total value
- $1.12B
- +$193.1M (+20.8%) vs. Q2 2022
- New holders
- 31
- 70 more added
- Sold out
- 15
- 30 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KDNY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $0 |
| Q4 2024 | 2 | $0 |
| Q3 2024 | 2 | $0 |
| Q2 2024 | 2 | $0 |
| Q1 2024 | 1 | $0 |
| Q4 2023 | 1 | $0 |
| Q3 2023 | 2 | $0 |
| Q2 2023 | 185 | $2.24B |
| Q1 2023 | 157 | $1.42B |
| Q4 2022 | 155 | $1.52B |
| Q3 2022 | 151 | $1.12B |
| Q2 2022 | 135 | $930.3M |
| Q1 2022 | 105 | $727.3M |
| Q4 2021 | 103 | $707.4M |
| Q3 2021 | 85 | $361.6M |
| Q2 2021 | 89 | $372.0M |
| Q1 2021 | 77 | $366.1M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Chinook Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of New York Mellon Corp | 210,492 | $4.14M | 0.00% | +17,710+9.2% | Added |
| Renaissance Technologies LLC | 219,342 | $4.31M | 0.01% | −53,620−19.6% | Reduced |
| Two Sigma Investments, LP | 220,945 | $4.34M | 0.02% | +2,662+1.2% | Added |
| Citadel Advisors LLC | 221,019 | $4.34M | 0.01% | +104,668+90.0% | Added |
| Ensign Peak Advisors, Inc | 236,905 | $4.66M | 0.01% | +50,808+27.3% | Added |
| Two Sigma Advisers, LP | 245,180 | $4.82M | 0.01% | +110,700+82.3% | Added |
| HealthCor Management, L.P. | 266,830 | $5.25M | 0.66% | +266,830 | New |
| Balyasny Asset Management LLC | 280,287 | $5.51M | 0.02% | +280,287 | New |
| Morgan Stanley | 285,458 | $5.61M | 0.00% | +54,724+23.7% | Added |
| Connor, Clark & Lunn Investment Management Ltd. | 287,284 | $5.65M | 0.04% | +166,342+137.5% | Added |
| Sofinnova Investments, Inc. | 287,901 | $5.66M | 0.36% | +11,292+4.1% | Added |
| Walleye Capital LLC | 297,384 | $5.85M | 0.13% | +20,846+7.5% | Added |
| Erste Asset Management GmbH | 307,769 | $6.05M | 0.14% | −15,000−4.6% | Reduced |
| Woodline Partners LP | 309,384 | $6.08M | 0.09% | −91,639−22.9% | Reduced |
| JPMorgan Chase & Co | 316,831 | $6.23M | 0.00% | +184,955+140.2% | Added |
| FMR LLC | 329,239 | $6.47M | 0.00% | −25,595−7.2% | Reduced |
| International Biotechnology Trust PLC | 340,389 | $6.68M | 2.14% | +334,442+5,623.7% | Added |
| Charles Schwab Investment Management Inc | 374,487 | $7.36M | 0.00% | +215,075+134.9% | Added |
| Millennium Management LLC | 398,969 | $7.84M | 0.01% | −786,264−66.3% | Reduced |
| Goldman Sachs Group Inc | 402,590 | $7.92M | 0.00% | +168,861+72.2% | Added |
| Northern Trust Corp | 422,035 | $8.30M | 0.00% | +33,528+8.6% | Added |
| Baillie Gifford & Co | 464,314 | $9.13M | 0.01% | −40,511−8.0% | Reduced |
| D. E. Shaw & Co., Inc. | 479,527 | $9.43M | 0.02% | +225,945+89.1% | Added |
| Rock Springs Capital Management LP | 507,512 | $9.98M | 0.26% | 00.0% | Unchanged |
| Altium Capital Management LP | 525,000 | $10.3M | 3.89% | −90,000−14.6% | Reduced |
| Sphera Funds Management Ltd. | 534,358 | $10.5M | 1.86% | −109,373−17.0% | Reduced |
| Nicholas Investment Partners, LP | 567,415 | $11.2M | 1.03% | +17,561+3.2% | Added |
| Pictet Asset Management SA | 682,112 | $13.4M | 0.02% | +682,112 | New |
| EcoR1 Capital, LLC | 690,000 | $13.6M | 0.40% | 00.0% | Unchanged |
| Affinity Asset Advisors, LLC | 813,998 | $16.0M | 7.38% | −123,570−13.2% | Reduced |
| Laurion Capital Management LP | 829,107 | $16.3M | 0.45% | −643−0.1% | Reduced |
| Candriam Luxembourg S.C.A. | 871,155 | $17.1M | 0.12% | 00.0% | Unchanged |
| Vivo Capital, LLC | 872,151 | $17.1M | 1.89% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 874,557 | $17.2M | 0.00% | +44,483+5.4% | Added |
| Driehaus Capital Management LLC | 881,684 | $17.3M | 0.26% | +389,381+79.1% | Added |
| Rubric Capital Management LP | 949,166 | $18.7M | 0.94% | 00.0% | Unchanged |
| Nuveen Asset Management, LLC | 961,258 | $18.9M | 0.01% | +336,054+53.8% | Added |
| Victory Capital Management Inc | 1,027,063 | $20.2M | 0.02% | +1,027,063 | New |
| Dimensional Fund Advisors LP | 1,113,744 | $21.9M | 0.01% | +281,338+33.8% | Added |
| Suvretta Capital Management, LLC | 1,390,000 | $27.3M | 1.15% | −394,200−22.1% | Reduced |
| Assenagon Asset Management S.A. | 1,431,394 | $28.1M | 0.12% | +369,512+34.8% | Added |
| OrbiMed Advisors LLC | 2,029,300 | $39.9M | 0.79% | +133,000+7.0% | Added |
| Vanguard Group Inc | 2,399,766 | $47.2M | 0.00% | +37,190+1.6% | Added |
| Point72 Asset Management, L.P. | 2,440,754 | $48.0M | 0.21% | +21,655+0.9% | Added |
| State Street Corp | 2,465,719 | $48.5M | 0.00% | +912,778+58.8% | Added |
| Baker Bros. Advisors LP | 2,534,102 | $49.8M | 0.33% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 2,551,703 | $50.2M | 8.66% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,000,000 | $59.0M | 2.91% | −430,110−12.5% | Reduced |
| BlackRock Inc. | 3,651,299 | $71.8M | 0.00% | +319,169+9.6% | Added |
| Frazier Life Sciences Management, L.P. | 4,265,559 | $83.9M | 6.46% | +670,533+18.7% | Added |
| Samsara BioCapital, LLC | 5,161,888 | $101.5M | 23.69% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −796,460−100.0% | Sold out |
| VR Adviser, LLC | 0 | $0 | 0.00% | −489,618−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −336,731−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −265,351−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −50,000−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −37,470−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −12,598−100.0% | Sold out |
| Weiss Multi-Strategy Advisers LLC | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| Janus Henderson Group PLC | 0 | $0 | 0.00% | −10,003−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,471−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −1,911−100.0% | Sold out |
| Monetary Management Group Inc | 0 | $0 | 0.00% | −150−100.0% | Sold out |
| State of Wyoming | 0 | $0 | 0.00% | −199−100.0% | Sold out |
| Signaturefd, LLC | 0 | $0 | 0.00% | −67−100.0% | Sold out |